# Jubilant Ingrevia wins Rs 270 crore specialty chemicals contract

Jubilant Ingrevia has received a CDMO contract worth Rs 270 crore from an international customer to supply two GMP intermediates for a patented drug over three years. Commercial supplies will start in the current financial year.

- Type: Contract
- Announced: 2022-04-18
- Where: India
- Value: $35.5M (2.70B INR)
- Status: announced
- Products: GMP intermediates for patented drugs
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Jubilant Ingrevia](https://endata.com/companies/62341.md) (supplier)

## Sources

- [economictimes.indiatimes.com](https://economictimes.indiatimes.com/markets/stocks/news/jubilant-ingrevia-zooms-6-on-bagging-rs-270-crore-specialty-chemicals-contract/articleshow/90905035.cms), 2022-04-18: "The pursuit of growth is one of the key features of our strategy. Today's announcement is in line with our strategy & commitment to grow our CDMO business of value-added GMP & Non GMP intermediates."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.